UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral Tecovirimat for the Treatment of Smallpox

The New England journal of medicine, 2018-07, Vol.379 (1), p.44-53

2018

Volltextzugriff (PDF)

Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys

PloS one, 2011-08, Vol.6 (8), p.e23237

2011

Volltextzugriff (PDF)

Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methods

PLoS pathogens, 2024-02, Vol.20 (2), p.e1012007-e1012007

2024

Volltextzugriff (PDF)

ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1367-1380

2015

Volltextzugriff (PDF)

Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential

Expert review of anti-infective therapy, 2023-03, Vol.21 (3), p.235-242

2023

Volltextzugriff (PDF)

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.15-25

2013

Volltextzugriff (PDF)

Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox)

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6246-6253

2013

Volltextzugriff (PDF)

Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Antimicrobial Agents and Chemotherapy, 2013-04, Vol.57 (4), p.1902-1912

2013

Volltextzugriff (PDF)

Identification of a Broad-Spectrum Arenavirus Entry Inhibitor

Journal of Virology, 2008-11, Vol.82 (21), p.10768-10775

2008

Volltextzugriff (PDF)

Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox Virus

Journal of Virology, 2011-09, Vol.85 (17), p.9176-9187

2011

Volltextzugriff (PDF)

Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001

The Journal of infectious diseases, 2012-11, Vol.206 (9), p.1372-1385

2012

Volltextzugriff (PDF)

Development of ST-246® for Treatment of Poxvirus Infections

Viruses, 2010-11, Vol.2 (11), p.2409-2435

2010

Volltextzugriff (PDF)

Effects of tillage and poultry manure application rates on Salmonella and fecal indicator bacteria concentrations in tiles draining Des Moines Lobe soils

Journal of environmental management, 2016-04, Vol.171, p.60-69

2016

Volltextzugriff (PDF)

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1817-1822

2009

Volltextzugriff (PDF)

Synergistic Efficacy of the Combination of ST-246 with CMX001 against Orthopoxviruses

Antimicrobial Agents and Chemotherapy, 2007-11, Vol.51 (11), p.4118-4124

2007

Volltextzugriff (PDF)

Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in Mice

Antimicrobial Agents and Chemotherapy, 2007-02, Vol.51 (2), p.689-695

2007

Volltextzugriff (PDF)

In Vitro Efficacy of ST246 against Smallpox and Monkeypox

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.1007-1012

2009

Volltextzugriff (PDF)

An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications

Expert review of anti-infective therapy, 2021-03, Vol.19 (3), p.331-344

2021

Volltextzugriff (PDF)

Evaluation of Lassa antiviral compound ST-193 in a guinea pig model

Antiviral research, 2011-04, Vol.90 (1), p.70-79

2011

Volltextzugriff (PDF)

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4900-4905

2012

Volltextzugriff (PDF)

ST-246 Inhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic Disease Manifestation

Antimicrobial Agents and Chemotherapy, 2009-12, Vol.53 (12), p.4999-5009

2009

Volltextzugriff (PDF)

Occurrence of neonicotinoids and sulfoxaflor in major aquifer groups in Iowa

Chemosphere (Oxford), 2021-10, Vol.281, p.130856, Article 130856

2021

Volltextzugriff (PDF)

Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (2), p.838-843

2010

Volltextzugriff (PDF)

The Vaccinia Virus F13L YPPL Motif Is Required for Efficient Release of Extracellular Enveloped Virus

Journal of Virology, 2007-07, Vol.81 (13), p.7310-7315

2007

Volltextzugriff (PDF)

Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

Antimicrobial Agents and Chemotherapy, 2008-05, Vol.52 (5), p.1721-1727

2008

Volltextzugriff (PDF)

1 – 25 von 954

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(813)
Mit Volltextzugriff
(772)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(529)
Life Sciences & Biomedicine
(459)
Animals
(331)
Biological And Medical Sciences
(249)
Humans
(231)
Male
(151)
Fundamental And Applied Biological Sciences. Psychology
(139)
Amino Acid Sequence
(137)
Pharmacology & Pharmacy
(125)
Medical Sciences
(115)
Mice
(111)
Molecular Sequence Data
(108)
Biochemistry & Molecular Biology
(107)
Female
(98)
Vaccinia Virus
(94)
Microbiology
(93)
Virology
(90)
Structure-Activity Relationship
(79)
Pharmacology. Drug Treatments
(73)
Chemistry
(70)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oral Tecovirimat for the Treatment of Smallpox

Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys

Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methods

ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping

Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox)

Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Identification of a Broad-Spectrum Arenavirus Entry Inhibitor

Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox Virus

Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001

Development of ST-246® for Treatment of Poxvirus Infections

Effects of tillage and poultry manure application rates on Salmonella and fecal indicator bacteria concentrations in tiles draining Des Moines Lobe soils

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

Synergistic Efficacy of the Combination of ST-246 with CMX001 against Orthopoxviruses

Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in Mice

In Vitro Efficacy of ST246 against Smallpox and Monkeypox

An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications

Evaluation of Lassa antiviral compound ST-193 in a guinea pig model

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

ST-246 Inhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic Disease Manifestation

Occurrence of neonicotinoids and sulfoxaflor in major aquifer groups in Iowa

Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice

The Vaccinia Virus F13L YPPL Motif Is Required for Efficient Release of Extracellular Enveloped Virus

Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

Suchergebnisse filtern